Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Haloperidol | 2 | 2018 | 78 | 0.87 | Why? |
| Nadroparin | 1 | 2018 | 9 | 0.76 | Why? |
| Anions | 1 | 2018 | 23 | 0.76 | Why? |
| Amikacin | 1 | 2019 | 62 | 0.76 | Why? |
| Citric Acid | 1 | 2018 | 116 | 0.69 | Why? |
| Hemofiltration | 1 | 2018 | 155 | 0.63 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.57 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.52 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.50 | Why? |
| Intensive Care Units, Pediatric | 1 | 2020 | 1098 | 0.50 | Why? |
| Antipsychotic Agents | 2 | 2018 | 887 | 0.48 | Why? |
| Critical Illness | 10 | 2022 | 17281 | 0.37 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.35 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.28 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.26 | Why? |
| Rotation | 1 | 2020 | 33 | 0.22 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.22 | Why? |
| Hydrogen Sulfide | 1 | 2021 | 86 | 0.20 | Why? |
| Stilbenes | 1 | 2021 | 113 | 0.20 | Why? |
| Alarmins | 1 | 2021 | 180 | 0.20 | Why? |
| Intensive Care Units | 8 | 2022 | 29594 | 0.20 | Why? |
| Citrates | 1 | 2018 | 37 | 0.18 | Why? |
| Acetylcysteine | 1 | 2021 | 255 | 0.18 | Why? |
| Electrolytes | 1 | 2018 | 103 | 0.17 | Why? |
| Delirium | 2 | 2018 | 1061 | 0.17 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.16 | Why? |
| Colistin | 1 | 2019 | 217 | 0.16 | Why? |
| APACHE | 1 | 2018 | 682 | 0.15 | Why? |
| Hypoglycemia | 2 | 2017 | 406 | 0.14 | Why? |
| Thrombelastography | 1 | 2020 | 627 | 0.14 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.14 | Why? |
| Bronchi | 1 | 2021 | 1048 | 0.14 | Why? |
| Nutritional Support | 1 | 2018 | 447 | 0.13 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.13 | Why? |
| Patients | 1 | 2020 | 1167 | 0.12 | Why? |
| Nurse's Role | 1 | 2020 | 614 | 0.12 | Why? |
| Respiration, Artificial | 1 | 2017 | 22116 | 0.11 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.11 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.10 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.10 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.09 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.09 | Why? |
| Body Mass Index | 1 | 2022 | 4306 | 0.09 | Why? |
| Anesthesia | 1 | 2018 | 1236 | 0.09 | Why? |
| Kidney | 1 | 2021 | 3648 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.08 | Why? |
| Hyperglycemia | 1 | 2016 | 1363 | 0.08 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Patient Acuity | 2 | 2022 | 1755 | 0.07 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.07 | Why? |
| Aged | 9 | 2022 | 215776 | 0.06 | Why? |
| Middle Aged | 10 | 2022 | 270681 | 0.06 | Why? |
| Blood Glucose | 1 | 2016 | 3642 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2016 | 1969 | 0.06 | Why? |
| Netherlands | 2 | 2022 | 3533 | 0.06 | Why? |
| Hospital Mortality | 3 | 2022 | 22087 | 0.06 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.06 | Why? |
| Simplified Acute Physiology Score | 1 | 2021 | 102 | 0.06 | Why? |
| Multiple Trauma | 1 | 2022 | 80 | 0.06 | Why? |
| Obesity | 1 | 2022 | 7388 | 0.05 | Why? |
| Humans | 17 | 2022 | 930598 | 0.05 | Why? |
| Male | 10 | 2022 | 367725 | 0.05 | Why? |
| Female | 10 | 2022 | 380317 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Intubation | 1 | 2021 | 437 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Toll-Like Receptors | 1 | 2021 | 365 | 0.05 | Why? |
| Oxidation-Reduction | 1 | 2021 | 540 | 0.05 | Why? |
| Mouth Floor | 1 | 2017 | 33 | 0.04 | Why? |
| Analysis of Variance | 1 | 2021 | 950 | 0.04 | Why? |
| Insulin | 2 | 2017 | 1316 | 0.04 | Why? |
| Adenosine | 1 | 2021 | 509 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.04 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2016 | 6166 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Pneumonia, Bacterial | 1 | 2022 | 843 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.03 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.03 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Sputum | 1 | 2021 | 1720 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Metabolic Syndrome | 1 | 2020 | 810 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2016 | 2165 | 0.02 | Why? |
| Length of Stay | 1 | 2022 | 11042 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Animals | 2 | 2021 | 78931 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Hospitalization | 1 | 2016 | 54280 | 0.00 | Why? |
| Retrospective Studies | 1 | 2016 | 105322 | 0.00 | Why? |
van der Voort's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_